Clinical Trial Update: Backup With Combivir or Single Dose (SD) Truvada in Order to Avoid Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) Resistance After SD Nevirapine for the Prevention of Mother-to-child Transmission (PMTCT) [NA]

View source ↗

Summary

Clinical trial update evaluating backup with Combivir or single-dose Truvada to prevent NNRTI resistance after a single-dose Nevirapine for prevention of mother…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• COMBIVIR (Lamivudine and Zidovudine)
• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)
• Viramune (Nevirapine)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: HIV Infections | NA | Status: COMPLETED